{"id":1698,"date":"2007-10-18T09:30:04","date_gmt":"2007-10-18T14:30:04","guid":{"rendered":"http:\/\/chimeraobscura.com\/vm\/sweet-and-sour\/"},"modified":"2007-10-18T14:51:28","modified_gmt":"2007-10-18T19:51:28","slug":"sweet-and-sour","status":"publish","type":"post","link":"http:\/\/chimeraobscura.com\/vm\/sweet-and-sour","title":{"rendered":"Sweet and sour"},"content":{"rendered":"<p>Pfizer has thrown in the towel on <a href=\"http:\/\/www.bloomberg.com\/apps\/news?pid=20601087&amp;sid=a9urg0qJuqKE\" target=\"_blank\">inhalable insulin<\/a>.<\/p>\n<p>Cafe Du Monde will continue to market <a href=\"http:\/\/www.cafedumonde.com\/beignetdemo.html\" target=\"_blank\">inhalable sugar<\/a>.<\/p>\n<p><em>(Update: Ooh! Snap! Nektar Therapeutics, Pfizer&#8217;s partner on Exubera, didn&#8217;t find out about Pfizer&#8217;s decision to bail on the drug <a href=\"http:\/\/www.nektar.com\/wt\/page\/pr_269991\/\" target=\"_blank\">until the announcement this morning<\/a>!)<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pfizer has thrown in the towel on inhalable insulin. Cafe Du Monde will continue to market inhalable sugar. (Update: Ooh! Snap! Nektar Therapeutics, Pfizer&#8217;s partner on Exubera, didn&#8217;t find out about Pfizer&#8217;s decision to bail on the drug until the announcement this morning!)<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[27,8,12],"tags":[],"class_list":["post-1698","post","type-post","status-publish","format-standard","hentry","category-big-business","category-new-orleans","category-pharmaceuticals"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p4C7K-ro","jetpack_likes_enabled":true,"jetpack-related-posts":[{"id":2096,"url":"http:\/\/chimeraobscura.com\/vm\/mobil-eyes","url_meta":{"origin":1698,"position":0},"title":"Mobil Eyes","author":"Gil","date":"June 11, 2008","format":false,"excerpt":"I didn't take any pix yesterday when I went to NYC to interview an exec at Pfizer, but that doesn't mean I didn't see any neat stuff. In this case, I discovered the Mobil Building, a block or so southwest of Pfizer's HQ. A gent named wallyg posted a neat\u2026","rel":"","context":"In &quot;Architecture&quot;","block_context":{"text":"Architecture","link":"http:\/\/chimeraobscura.com\/vm\/category\/architecture"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/chimeraobscura.com\/vm\/wp-content\/uploads\/mobil.jpg?resize=350%2C200","width":350,"height":200},"classes":[]},{"id":1695,"url":"http:\/\/chimeraobscura.com\/vm\/unrequired-reading-oct-19-2007","url_meta":{"origin":1698,"position":1},"title":"Unrequired Reading: Oct. 19, 2007","author":"Gil","date":"October 19, 2007","format":false,"excerpt":"Have a good weekend, dear readers! There are plenty of links awaiting you! Just click \"more\"! I'm proud to say that I've never seen a single one of these movies. * * * Design isn't always important in advertising, but it is important not to come off as creepy when\u2026","rel":"","context":"In &quot;Adventures in Gin&quot;","block_context":{"text":"Adventures in Gin","link":"http:\/\/chimeraobscura.com\/vm\/category\/adventures-in-gin"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":586,"url":"http:\/\/chimeraobscura.com\/vm\/american-job-destruction-act","url_meta":{"origin":1698,"position":2},"title":"American Job Destruction Act","author":"Gil","date":"July 25, 2005","format":false,"excerpt":"When I write my annual Top 20 Pharma Companies & Top 10 Biopharma Companies report (this year's edition is soon to post at the website of my day job), I read a lot of annual reports, along with industry analysis, news coverage, and other neat sources. The annual reports have\u2026","rel":"","context":"In &quot;Pharmaceuticals&quot;","block_context":{"text":"Pharmaceuticals","link":"http:\/\/chimeraobscura.com\/vm\/category\/big-business\/pharmaceuticals"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":1801,"url":"http:\/\/chimeraobscura.com\/vm\/what-am-i-a-farmer","url_meta":{"origin":1698,"position":3},"title":"What am I, a farmer?","author":"Gil","date":"November 28, 2007","format":false,"excerpt":"Last night, I was writing to a buddy about how tired I was from my autumn biz-travel schedule. I think I was attempting to elicit sympathy for going to Milan, Las Vegas and San Diego over the course of 6 weeks. \"Boy, you think you've got it tough. . .\"\u2026","rel":"","context":"In &quot;Big Business&quot;","block_context":{"text":"Big Business","link":"http:\/\/chimeraobscura.com\/vm\/category\/big-business"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":17,"url":"http:\/\/chimeraobscura.com\/vm\/drug-deal","url_meta":{"origin":1698,"position":4},"title":"Drug Deal","author":"Gil","date":"April 28, 2003","format":false,"excerpt":"I'm on a press trip in Puerto Rico this week, as mentioned earlier, and it's been sorta tough to get any blogging done. The perfect sunlight tends to, um, make too much glare on the laptop's screen. Yeah, that's it.Anyway, this morning, before heading out to the beach from my\u2026","rel":"","context":"Similar post","block_context":{"text":"Similar post","link":""},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":910,"url":"http:\/\/chimeraobscura.com\/vm\/more-on-job-destruction","url_meta":{"origin":1698,"position":5},"title":"More on Job Destruction","author":"Gil","date":"April 16, 2006","format":false,"excerpt":"Last July, I wrote about the nuttiness of the American Jobs Creation Act, a one-time tax break for companies bringing overseas profits back to the U.S. (the tax rate on such earnings drops from about 38% to about 5%). Michelle Leder at Slate just wrote about the subject, calling it\u2026","rel":"","context":"In &quot;Pharmaceuticals&quot;","block_context":{"text":"Pharmaceuticals","link":"http:\/\/chimeraobscura.com\/vm\/category\/big-business\/pharmaceuticals"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"_links":{"self":[{"href":"http:\/\/chimeraobscura.com\/vm\/wp-json\/wp\/v2\/posts\/1698","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/chimeraobscura.com\/vm\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/chimeraobscura.com\/vm\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/chimeraobscura.com\/vm\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/chimeraobscura.com\/vm\/wp-json\/wp\/v2\/comments?post=1698"}],"version-history":[{"count":0,"href":"http:\/\/chimeraobscura.com\/vm\/wp-json\/wp\/v2\/posts\/1698\/revisions"}],"wp:attachment":[{"href":"http:\/\/chimeraobscura.com\/vm\/wp-json\/wp\/v2\/media?parent=1698"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/chimeraobscura.com\/vm\/wp-json\/wp\/v2\/categories?post=1698"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/chimeraobscura.com\/vm\/wp-json\/wp\/v2\/tags?post=1698"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}